Abstract

Background Previous researches indicate that Itpr2−/− mice (inositol 1,4,5-trisphosphate receptor type 2 knockout mice) show depressive-like symptoms; however, little is known regarding the in vivo neurobiological effect of Itpr2 as well as the specific pattern of brain abnormalities in Itpr2−/− mice. Methods/Materials. First, behavioral tests, structural magnetic resonance imaging (MRI), and resting-state functional MRI were performed on Itpr2−/− mice and matched healthy controls. Voxel-based morphometry and seed-based voxel-wise functional connectivity (FC) were, respectively, calculated to assess the gray matter volume and the functional activities of the brain in vivo. Second, the sample of relevant changed brain regions was extracted to detect the expression of BDNF. Finally, to further validate the relationship between Itpr2 deficiency and the observed brain abnormalities, we performed Western blotting to detect the expression of pro-BDNF and mBDNF in Itpr2−/− C8-D1A (a type of astrocyte). Results Compared with controls, Itpr2−/− mice showed depressive-like behaviors as well as significantly lower gray matter volume in striatums mainly, periaqueductal GM, and the right frontoparietal cortices as well as lower striatal-hippocampal and striatal-right parietal cortex (mainly for the primary and secondary somatosensory cortex) FC. Moreover, decreased expression of mBDNF was found in both sample tissues of the striatum in Itpr2−/− mice and Itpr2−/− C8-D1A. Conclusion By combining biochemistry and MR analyses, this study provides evidences to support that the Itpr2-related neuropathological effect is possibly mediated by the striatal abnormality associated with dysfunctional astrocytes in Itpr2−/− mice in vivo, thus may help us better understand underlying mechanisms of Itpr2 deficiency as well as its relation to depressive-like behavior.

Highlights

  • BackgroundPrevious researches indicate that Itpr2-/- mice (inositol 1,4,5-trisphosphate receptor type 2 knockout mice) show depressive-like symptoms; little is known regarding the in vivo neurobiological effect of Itpr as well as the specific pattern of brain abnormalities in Itpr2-/- mice

  • Inositol 1,4,5-trisphosphate receptor type 2 (IP3R2) is a calcium channel receptor located in the endoplasmic reticulum, which is mainly expressed in astrocytes other than other types of cell in the brain [1]

  • It is considered to be necessary to maintain the normal function in astrocytes especially the exocytosis by which brain-derived neurotrophic factor (BDNF) and ATP are released to extracellular matrix [2]

Read more

Summary

Background

Previous researches indicate that Itpr2-/- mice (inositol 1,4,5-trisphosphate receptor type 2 knockout mice) show depressive-like symptoms; little is known regarding the in vivo neurobiological effect of Itpr as well as the specific pattern of brain abnormalities in Itpr2-/- mice. To further validate the relationship between Itpr deficiency and the observed brain abnormalities, we performed Western blotting to detect the expression of pro-BDNF and mBDNF in Itpr2-/- C8-D1A (a type of astrocyte). Itpr2-/- mice showed depressive-like behaviors as well as significantly lower gray matter volume in striatums mainly, periaqueductal GM, and the right frontoparietal cortices as well as lower striatalhippocampal and striatal-right parietal cortex (mainly for the primary and secondary somatosensory cortex) FC. By combining biochemistry and MR analyses, this study provides evidences to support that the Itpr2-related neuropathological effect is possibly mediated by the striatal abnormality associated with dysfunctional astrocytes in Itpr2-/mice in vivo, may help us better understand underlying mechanisms of Itpr deficiency as well as its relation to depressive-like behavior

Introduction
Materials and Methods
Behavioral Test
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.